Log In
Print
BCIQ
Print
Print this Print this
 

inclacumab (RG1512) (formerly R1512)

  Manage Alerts
Collapse Summary General Information
Company Genmab A/S
DescriptionRecombinant human mAb targeting P selectin (SELP; CD62P)
Molecular Target P selectin (SELP) (CD62P)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today